Mangoceuticals, Inc. Current Liabilities
Mangoceuticals, Inc. (MGRX) had Current Liabilities of $1.40 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $1.40M.
- 2026-03-31: Liabilities, Current $737.61K.
- 2025-12-31: Liabilities, Current $890.57K.
- 2025-09-30: Liabilities, Current $804.27K.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $1.40M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $737.61K 10-Q · filed 2026-05-19 |
| 2025-12-31 | $890.57K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $804.27K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $1.60M 10-Q/A · filed 2025-11-14 |
| 2025-03-31 | $1.50M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.43M 10-K · filed 2026-04-01 |
| 2024-09-30 | $1.39M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.38M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $1.21M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $211.08K 10-K · filed 2025-03-20 |
| 2023-09-30 | $159.18K 10-Q · filed 2023-10-27 |
| 2023-06-30 | $196.48K 10-Q · filed 2023-07-28 |
| 2023-03-31 | $182.84K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $260.58K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |